Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 16.46 M13.57 M14.59 M17 M14.94 M 60.1 M Research & development ————— — Operating income 5.01 M-209 K-11.31 M-210.38 M-19.7 M -241.6 M Non-Operating Income, Total 769 K305 K669 K341 K180 K 1.5 M Interest expense, net of interest capitalized 8.87 M9.98 M9.17 M9 M8.68 M 36.83 M Non-Operating Income, excl. Interest Expenses -8.85 M-9.86 M-9.14 M-8.84 M-8.57 M -36.41 M Unusual income/expense 743 K182 K639 K180 K74 K 1.07 M Pretax income 219.18 M200.63 M205.38 M77.54 M153.95 M 637.5 M Equity in earnings 2.69 M-1.19 M6.63 M-9.42 M2.14 M -1.84 M Taxes -313 K-61 K57.19 M-323 K19 K 56.83 M Non-controlling/minority interest 1.77 M416 K-1.71 M-2.29 M174 K -3.42 M After tax other income/expense ————— — Net income before discontinued operations -4.55 M-10.31 M-75.27 M-216.41 M-28.35 M -330.34 M Discontinued operations ————— — Net income -4.55 M-10.31 M-75.27 M-216.41 M-28.35 M -330.34 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -4.55 M-10.31 M-75.27 M-216.41 M-28.35 M -330.34 M Basic earnings per share (Basic EPS) -0.08-0.19-1.39-4.01-0.52 -6.11 Diluted earnings per share (Diluted EPS) -0.08-0.19-1.39-4.01-0.52 -6.11 Average basic shares outstanding 53.96 M54.01 M54.11 M54.05 M54.12 M — Diluted shares outstanding 53.96 M54.01 M54.11 M54.05 M54.12 M — EBITDA ——-10.84 M-210.38 M-9.39 M — EBIT 15.98 M-209 K-11.31 M-210.38 M-9.87 M -231.76 M Cost of revenue 218.01 M202.02 M210.07 M297.33 M177.16 M 886.58 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) ——471 K0471 K —